“Hunger Hormone” Linked To Memory Deficits In Alzheimer’s Disease

Date:

Whenever we feel hungry, our body is producing a hormone called Ghrelin. It’s also called the “hunger hormone” because of the role it plays in promoting appetite. Secreted by the gastrointestinal tract, it can cross the blood-brain barrier and finally triggers brain cells in the hypothalamus to signal that we are ready to eat.

Scientists believe that the hunger hormone is also active in the hippocampus, which is known as the ‘”memory center” of the brain. The current hypothesis is that it plays an important role in learning and memory. Previous studies have explored whether activating ghrelin receptors in the hippocampus can slow down Alzheimer’s. The results are inconclusive for animals and humans, but the latest research suggests that cognitive activity in a healthy hippocampus requires activity from ghrelin and dopamine receptors.

Hunger hormone
Credit: The University of Texas at Dallas

Heng Du, corresponding author on the new research said:

Our hypothesis that this dissociation between ghrelin and dopamine receptors may be what is affecting cognition in Alzheimer’s patients, when the brain loses the function of ghrelin receptors because of amyloid beta, the body tries to compensate to increase production of ghrelin and the number of ghrelin receptors.the amyloid prevents the receptors from functioning.

The Body Producing What It Needs

Heng Du suggests that this process is like the way insulin receptors malfunction in patients with type 2 diabetes. Despite how much insulin is present in the body, the fundamental mechanism is dysfunctional. So too he thinks with hippocampal deficits seen in Alzheimer’s disease. While ghrelin deficiency could play a role, administering extra ghrelin or trying to activate ghrelin receptors may prove to not be an effective approach.

They outline this new approach in a paper published in the journal Science Translational Medicine. It suggests a simultaneous activation of both ghrelin and dopamine in the hippocampus may be the solution. To test this approach, they administered Alzheimer’s modeled mice with two compounds designed to trigger both receptors.

Heng Du explained: “When we administered these compounds simultaneously, we saw improved cognition and memory in the Alzheimer infected mice, and it reduced lesions in the hippocampus. Activating both the receptors simultaneously was key; it restored the receptors’ ability to form complexes. When this happens, we suspect the ghrelin receptor becomes protected and can no longer bind to amyloid beta.”

Finding Order In The Chaos

This research still has a long road ahead. The study is basically a proof of concept supporting the potential effectiveness of targetting this neural mechanism to slow down and even stop cognitive decline associated with not only Alzheimers but also with aging.

“We know that even in the absence of dementia. Many older people have memory problems, and they could relate this to the dissociation between the receptors in the brain, even without the presence of amyloid,” says Heng Du.

The study implies that Alzheimer’s may be a broader systemic disorder. Should cognitive symptoms associate with more general metabolic or hormonal pathways, then hypothetically there could be several ways to inhibit its onset. Together this provides an additional layer of evidence as to the causes of Alzheimer’s and opens the door for more effective neural targeting and treatment of this disease.

Skunk Ohm
Skunk Ohm
I love all things nature and technology.

Share post:

Popular

How Green Interiors Are Redefining the Healthy Workplace

For decades, the standard office looked the same everywhere....

Personalized mRNA Melanoma Vaccine Cuts Recurrence 42% in Phase 3

A personalized mRNA melanoma vaccine built for each patient's...

5 Comfortable Transport Wheelchairs for Seniors and Post-Surgery Recovery

Mobility may pose a challenge when it comes to...

Biodegradable Plastic Landfill Test: 99.9% vs 2.7% in 320 Days

Not all biodegradable plastic rots. In a 320-day test...